Nom du produit:Ethyl 4-chloroimidazo[1,2-a]quinoxaline-2-carboxylate

IUPAC Name:ethyl 4-chloroimidazo[1,2-a]quinoxaline-2-carboxylate

CAS:1251013-95-2
Formule moléculaire:C13H10ClN3O2
Pureté:97%
Numéro de catalogue:CM222439
Poids moléculaire:275.69

Unité d'emballage Stock disponible Prix($) Quantité
CM222439-1g 3-4 Weeks Ŵǧƻ
CM222439-5g 3-4 Weeks ȬțȁƱ
CM222439-10g 3-4 Weeks ȬɅɅƱ
CM222439-25g 3-4 Weeks ƀɅƱƙ

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:1251013-95-2
Formule moléculaire:C13H10ClN3O2
Point de fusion:-
Code SMILES:O=C(C1=CN2C(C(Cl)=NC3=C2C=CC=C3)=N1)OCC
Densité:
Numéro de catalogue:CM222439
Poids moléculaire:275.69
Point d'ébullition:
N° Mdl:
Stockage:

Category Infos

Quinoxalines
Quinoxalines, also known as benzopyrazines, are heterocyclic compounds containing a ring complex consisting of a benzene ring and a pyrazine ring. It has isomerism with other naphthalene compounds such as quinazoline, phthalazine, cinnamine, etc. Fusion N-heterocyclic compounds are widely used as valuable entities for the expansion of important pharmacological agents and are considered to be an advantageous scaffold material. Among the numerous fused N-heterocyclic compounds, cinnoline, quinoxaline and quinazoline are important pharmacological agents. In medicinal chemistry, these N-heterocyclic compounds have a wide range of biological properties and can be used as synthetic intermediates, potential drug candidates and chemical probes.
Imidazopyrazines
In addition to the nitrogen-based heterocycles presented so far, a number of others nitrogen-based scaffolds have also been reported as promising agents for GBM treatment, including pyrazolo-triazole, imidazotetrazine, piperidine, purine, imidazopyrazine, pyrazole, triazole among others.

Related Products